Advance Agrolife (ADVANCE) Q2 FY27 Profit Plunges 47% as Costs Outrun Sales Growth
The agrochemical firm's revenue rose 35% from a year ago, but a sharp margin squeeze and higher interest costs led to a steep quarterly profit decline.
Advance Agrolife posted a 35% YoY revenue jump in Q2 FY27, but net profit fell 24%. The quarter saw a severe margin contraction as raw material costs surged, overshadowing strong top-line demand.
For agrochemical makers, the story is often about balancing volume growth against the volatile cost of ingredients. Advance Agrolife’s September quarter shows what happens when that balance tips. Revenue surged on healthy demand, but profits were nearly halved from the prior quarter as costs raced ahead.
The numbers tell a story of divergence. Revenue stood at ₹287 crore, up 35% from a year ago. Yet, net profit fell to ₹12 crore, down 24% year-on-year and a steep 47% from the June quarter. The net profit margin compressed to 4.2%, down 330 basis points from last September.
Revenue & profit
Revenue (₹ Cr)
Profit (₹ Cr)
Net Profit Margin
| Metric | CurrentQ2 FY27 (Sep 2026) | PreviousQ1 FY27 (Jun 2026) |
|---|---|---|
| Revenue (₹ Cr) | 287.0 | 330.4 |
| Profit (₹ Cr) | 12.0 | 22.55 |
| Net Profit Margin | 4.2% | 6.8% |
Why margins collapsed
The profit squeeze came from two sides. First, raw material costs rose sharply, compressing operating margins. According to the investor presentation cited by Arthneeti, EBITDA margin fell to 7.6% from 12.1% a year ago.
Second, finance costs jumped 48% sequentially, pressuring profits further. This reflects higher borrowings likely tied to the company’s ongoing capacity expansion. The sales growth itself came with a cash flow catch, as trade receivables ballooned, notes ScanX.
The path to recovery
Management’s plan hinges on a structural shift. The company aims to move from a pure formulator to an integrated manufacturer of technical-grade chemicals. This backward integration, outlined in its presentation, targets a 25-30% reduction in production costs for key products like fungicides.
Major capacity additions are underway. A new 2,4-D herbicide plant will quadruple capacity by Q4 FY28. Another facility for technical-grade products aims to improve margins. The goal is to lift exports from 2% to 20% of revenue by FY29.
A sector under pressure
The company’s margin pain is not unique. Commentary from Rallis India’s earnings call, reported by Yahoo Finance, highlights a sector grappling with excess supply, low disease pressure, and pricing pressure from Chinese imports. This environment makes it hard to pass on higher input costs.
The immediate market read was neutral, according to SAHI, balancing strong revenue against weak margins. With cash from operations trailing reported profit, the focus is on whether upcoming capacity can deliver the promised cost savings before working capital strains intensify.
Key Points
- Revenue grew 35% year-on-year to ₹287 crore, demonstrating strong volume demand for agrochemicals.
- Net profit fell 47% quarter-on-quarter to ₹12 crore, hit by a sharp contraction in EBITDA margin and rising finance costs.
- Management is betting on backward integration and capacity expansion to structurally improve margins over the medium term.
- The sector faces headwinds from competitive pricing and volatile raw material costs, limiting near-term pricing power.
Hexa Perspective
Advance Agrolife’s quarter underscores the classic formulation trap: growth that doesn't reach the bottom line. The 330-bps yearly margin decline is severe, and the sequential profit drop suggests the cost pinch intensified.
The investment case now rests entirely on the execution of its integration strategy. If the new technical plants deliver the targeted 25-30% cost savings, margins could recover meaningfully. Until then, with sector pricing weak and receivables high, earnings volatility is likely to persist. Investors are paying for a transition that has yet to materialize.
Also read
Want this applied to your portfolio?
Talk to a HexaWealth advisor, or sync your mutual fund data for insights tailored to your holdings.
